March 21, 2025 11:19 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Finland is world's happiest country, India slightly improves its happiness quotient with 118th position | 'I have a very good relationship with India but they're one of the highest tariffing nations': Donald Trump | Chhattisgarh: 22 Maoists, one jawan killed in two encounters | Rana Daggubati, Vijay Deverakonda, Prakash Raj among 25 celebs booked for promoting illegal betting apps | India outplay Maldives 3-0 in FIFA International Friendly | Indian researcher in US detained, faces deportation over alleged link to Hamas | Donald Trump will back Volodymyr Zelenskyy get more air defence from Europe: White House | Punjab Police detain farmer leaders in Mohali, cops remove protesters from Shambhu border | Meerut Merchant navy officer murder: Wife convinced boyfriend to commit crime with Snapchat texts posing as his dead mother | 'Welcome back, the Earth missed you': PM Modi to Sunita Williams on her return from Space

CCI approves merger of Serum Institute subsidiaries Biocon Biologics and CTPL

May 20, 2022, at 12:09 am

New Delhi: The Competition Commission of India (CCI) has approved the merger by absorption of Covidshield Technologies into Biocon Biologics in consideration for the acquisition of approximately 15 percent equity shareholding of Biocon Biologics by Serum Institute Life Sciences.

SII buys 50 pc stake in pharma packaging firm Schott Kaisha

Aug 18, 2021, at 06:41 am

Pune/IBNS: Pune-based manufacturer of AstraZeneca vaccine, Covishield, Serum Institute of India (SII) has acquired a 50 per cent stake in SCHOTT Kaisha to become SCHOTT's joint venture partner and secure the pharma packaging supply, the pharma company announced on Tuesday.

Boris Johnson announces Serum Institute of India to invest 240 million pounds in UK

May 04, 2021, at 05:09 pm

London: British PM Boris Johnson has announced the Serum Institute of India (SII), the manufacturers of COVID-19 vaccine Covishield, will be investing 240 million pounds in the United Kingdom through the opening of a new sales office, media reports said.

Close menu